Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(3)

Detailed Status

Completed3

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed3100%

Recent Activity

0 active trials
Showing 3 of 3
completednot_applicable

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

NCT06068894
completednot_applicable

Exercise and Galactooligosaccharide Supplementation on Inflammation and Iron Absorption (FexerGOS)

NCT06038656
completednot_applicable

GOS to Reduce Symptom Severity in IBS

NCT05157061

Clinical Trials (3)

Showing 3 of 3 trials
NCT06068894Not Applicable

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

Completed
NCT06038656Not Applicable

Exercise and Galactooligosaccharide Supplementation on Inflammation and Iron Absorption (FexerGOS)

Completed
NCT05157061Not Applicable

GOS to Reduce Symptom Severity in IBS

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3